Psychomotor performance in relation to acute oral administration of Δ9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects (original) (raw)

• Andreasson S, Allebeck P, Engstrom A, Rydberg U (1987) Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 2:1483–1486
  Article PubMed CAS Google Scholar
• Bisogno T, Hanus L, De Petrocelis L, Tehilibon S, Ponde DE, Brandi I, Moriello AS, Davies JB, Mechoulam R, Di Marzo V (2001) Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134:845–852
  Article PubMed CAS Google Scholar
• Bloom JS, Hynd GW (2005) The role of the corpus callosum in interhemispheric transfer of information: excitation or inhibition? Neuropsychol Rev 15:59–71
  Article PubMed Google Scholar
• Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211–218
  Google Scholar
• Bornheim LM, Grillo MP (1998) Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator. Chem Res Toxicol 11:1209–1216
  Article PubMed CAS Google Scholar
• Breivogel CS, Griffin G, Di Marzo V, Martin BR (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60:155–163
  PubMed CAS Google Scholar
• Chan PK, Chan SC, Yung WH (1998) Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist. Neuroreport 9:671–675
  Article PubMed CAS Google Scholar
• Crow TJ, Colter N, Frith CD, Johnstone EC, Owens DGC (1989) Developmental arrest of cerebral asymmetries in early onset schizophrenia. Psychiatry Res 29:247–253
  Article PubMed CAS Google Scholar
• Dean B, Sundram S, Bradbury R, Scarr E, Copolov D (2001) Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 103:9–15
  Article PubMed CAS Google Scholar
• Doty RW (1989) Schizophrenia: a disease of interhemispheric processes at forebrain and brainstem levels? Behav Brain Res 34:1–33
  Article PubMed CAS Google Scholar
• D’Souza DC (2007) Cannabinoids and psychosis. Int Rev Neurobiol 78:289–326
  Article PubMed CAS Google Scholar
• Emrich HM, Leweke FM, Schneider U (1997) Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav 56:803–807
  Article PubMed CAS Google Scholar
• Flyckt L, Sydow O, Bjerkenstedt L, Edman G, Rydin E, Wiesel FA (1999) Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls. Psychiatry Res 86:113–129
  Article PubMed CAS Google Scholar
• Gold S, Arndt S, Nopoulos P, O’Leary DS, Andreasen NC (1999) Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am J Psychiatry 156:1342–1348
  PubMed CAS Google Scholar
• Goode DJ, Manning AA (1988) Specific imbalance of right and left sided motor neuron excitability in schizophrenia. J Neurol Neurosurg Psychiatry 51:626–629
  Article PubMed CAS Google Scholar
• Goode DJ, Manning AA, Middleton JF, Williams B (1981) Fine motor performance before and after treatment in schizophrenic and schizoaffective patients. Psychiatry Res 5:247–255
  Article PubMed CAS Google Scholar
• Gorynia I, Campman V, Uebelhack R (2003) Intermanual coordination in relation to different clinical subgroups in right-handed patients with schizophrenic and other psychotic disorders. Eur Arch Psychiatry Clin Neurosci 253:53–59
  Article PubMed Google Scholar
• Gorynia I, Dudeck U, Neumärker KJ (1994) Instability in functional motor laterality of children and adolescents with endogenous psychosis and predominantly motor disturbances. Eur Arch Psychiatry Clin Neurosci 244:33–38
  Article PubMed CAS Google Scholar
• Gorynia I, Egenter D (2000) Intermanual coordination in relation to handedness, familial sinistrality and lateral preferences. Cortex 36:1–18
  Article PubMed CAS Google Scholar
• Gorynia I, Uebelhack R (1992) Functional motor asymmetries correlated with clinical findings in unmedicated schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 242:39–45
  Article PubMed CAS Google Scholar
• Grotenhermen F (2005) Cannabinoids. Curr Drug Targets CNS Neurol Disord 4:507–530
  Article PubMed CAS Google Scholar
• Günther W, Günther R, Eich FX, Eben E (1986) Psychomotor disturbances in psychiatric patients as a possible basis for new attempts at differential diagnosis and therapy. II. Cross validation study on schizophrenic patients: persistence of a “psychotic motor syndrome” as possible evidence of an independent biological marker syndrome for schizophrenia. Eur Arch Psychiatry Neurol Sci 235:301–308
  Article PubMed Google Scholar
• Gupta S, Andreasen NC, Arndt S, Flaum M, Schultz SK, Hubbard WC, Smith M (1995) Neurological soft signs in neuroleptic-naive and neuroleptic treated schizophrenic patients and in normal comparison subjects. Am J Psychiatry 152:191–196
  PubMed CAS Google Scholar
• Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932–1936
  Article PubMed CAS Google Scholar
• Hokama H, Shenton ME, Nestor PG, Kikinis R, Levitt JJ, Metcalf D, Wible CG, O’Donnell BF, Jolesz FA, McCarley RW (1995) Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study. Psychiatry Res 61:209–229
  Article PubMed CAS Google Scholar
• Iversen L (2003) Cannabis and the brain. Brain 126:1252– 1270
  Article PubMed Google Scholar
• Johns A (2001) Psychiatric effects of cannabis. Br J Psychiatry 178:116–122
  Article PubMed CAS Google Scholar
• Juckel G, Roser P, Nadulski T, Stadelmann AM, Gallinat J (2007) Acute effects of delta-9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity. Schizophr Res 97:109–117
  Article PubMed Google Scholar
• Levander SE, Bartfai A, Schalling D (1985) Regional cortical dysfunction in schizophrenic patients studied by computerized neuropsychological methods. Percept Mot Skills 61:479–495
  PubMed CAS Google Scholar
• Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D (1999) Elevated endogenous cannabinoids in schizophrenia. Neuroreport 10:1665–1669
  Article PubMed CAS Google Scholar
• Lezak MD (1995) Neuropsychological assessments, 3rd edn. Oxford University Press, New York
  Google Scholar
• Martinez-Arevalo MJ, Calcedo-Ordonez A, Varo-Prieto JR (1994) Cannabis consumption as a prognostic factor in schizophrenia. Br J Psychiatry 164:679–681
  Article PubMed CAS Google Scholar
• Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561–564
  Article PubMed CAS Google Scholar
• Mechoulam R, Gaoni Y (1965) A total synthesis of delta-1-tetrahydrocannabinol, the active constituent of hashish. J Am Chem Soc 87:3273–3275
  Article PubMed CAS Google Scholar
• Mechoulam R, Parker LA, Gallily R (2002) Cannabidiol: an overview of some pharmacological aspects. J Clin Pharmacol 42:11S–19S
  PubMed CAS Google Scholar
• Nadulski T, Pragst F, Weinberg G, Roser P, Schnelle M, Fronk EM, Stadelmann AM (2005) Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract. Ther Drug Monit 27:799–810
  Article PubMed CAS Google Scholar
• Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97–113
  Article PubMed CAS Google Scholar
• Pelletier J, Suchet L, Witjas T, Habib M, Guttmann CR, Salamon G, Lyon-Caen O, Chérif AA (2001) A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Arch Neurol 58:105–111
  Article PubMed CAS Google Scholar
• Pertwee RG (2008) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. Br J Pharmacol 153:199–215
  Article PubMed CAS Google Scholar
• Pycock CJ, Kilpatric IC (1989) Motor asymmetries and drug effects: behavioral analyses of receptor activation. In: Boulton AA, Baker GB, Greenshaw AJ (eds) Neuromethods, vol 13: psychopharmacology. Human Press, Clifton, pp 1–93
  Google Scholar
• Rodriguez de Fonseca F, Del Arco I, Martin-Calderon JL, Gorriti MA, Navarro M (1998) Role of the endogenous cannabinoid system in the regulation of motor activity. Neurobiol Dis 5:483–501
  Article PubMed CAS Google Scholar
• Rodriguez de Fonseca F, Gorriti MA, Bilbao A, Escuredo L, Garcia-Segura LM, Piomelli D, Navarro M (2001) Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson’s disease and schizophrenia. Neurotox Res 3:23–35
  PubMed CAS Google Scholar
• Roser P, Vollenweider FX, Kawohl W (2008) Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists. World J Biol Psychiatry 7:1–12. DOI: 10.1080/15622970801908047
  Google Scholar
• Roser P, Juckel G, Rentzsch J, Nadulski T, Gallinat J, Stadelmann AM (2008) Effects of acute oral Delta(9)-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers. Eur Neuropsychopharmacol 18:569–577
  Article PubMed CAS Google Scholar
• Roser P, Stadelmann AM, Arning L, Gallinat J, Epplen JT, Juckel G (2008) Acute effects of Δ9-tetrahydrocannabinol on the auditory event-related mismatch negativity depending on genetic variations in the dysbindin, neuregulin and G72 gene. Int J Neuropsychopharmacol 11(Suppl 1):256
  Google Scholar
• Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ (2007) The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152:1092–1101
  Article PubMed CAS Google Scholar
• Sañudo-Peña MC, Romero J, Seale GE, Fernandez-Ruiz JJ, Walker JM (2000) Activational role of cannabinoids on movement. Eur J Pharmacol 391:269–274
  Article PubMed Google Scholar
• Sañudo-Peña MC, Tsou K, Walker JM (1999) Motor actions of cannabinoids in the basal ganglia output nuclei. Life Sci 65:703–713
  Article PubMed Google Scholar
• Sauerwein HC, Lassonde M (1994) Cognitive and sensori-motor functioning in the absence of the corpus callosum: neuropsychological studies in callosal agenesis and callosotomized patients. Behav Brain Res 64:229–240
  Article PubMed CAS Google Scholar
• Schmidt SL, Oliveira RM, Krahe TE, Filgueiras CC (2000) The effects of hand preference and gender on finger tapping performance asymmetry by the use of an infra-red light measurement device. Neuropsychologia 38:529–534
  Article PubMed CAS Google Scholar
• Shakow D, Huston PE (1936) Studies on motor function in schizophrenia: I. Speed of tapping. J Gen Psychol 15:63–106
  Google Scholar
• Shaw JC, Colter N, Resek G (1983) EEG coherence, lateral preference and schizophrenia. Psychol Med 13:299–306
  Article PubMed CAS Google Scholar
• Shimoyama I, Ninchoji T, Uemura K (1990) The finger-tapping test. A quantitative analysis. Arch Neurol 47:681–684
  PubMed CAS Google Scholar
• Solowij N (1998) Cannabis and cognitive functioning. Cambridge University Press, Cambridge
  Google Scholar
• Stratta P, Rossi A, Gallucci M, Amicarelli I, Passariello R, Casacchia M (1989) Hemispheric asymmetries and schizophrenia: a preliminary magnetic resonance imaging study. Biol Psychiatry 25:275–284
  Article PubMed CAS Google Scholar
• Strik W, Dierks T (2008) Neurophysiological mechanisms of psychotic symptoms. Eur Arch Psychiatry Clin Neurosci 258(Suppl 5):66–70
  Article PubMed Google Scholar
• Struve FA, Straumanis JJ, Patrick G (1994) Persistent topographic quantitative EEG sequelae of chronic marihuana use: a replication study and initial discriminant function analysis. Clin Electroencephalogr 25:63–75
  PubMed CAS Google Scholar
• Struve FA, Straumanis JJ, Patrick G, Leavitt J, Manno JE, Manno BR (1999) Topographic quantitative EEG sequelae of chronic marihuana use: a replication using medically and psychiatrically screened normal subjects. Drug Alcohol Depend 56:167–179
  Article PubMed CAS Google Scholar
• Szabo B, Wallmichrath I, Mathonia P, Pfreundtner C (2000) Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata. Neuroscience 97:89–97
  Article PubMed CAS Google Scholar
• Torrey E (1980) Neurological abnormalities in schizophrenic patients. Biol Psychiatry 15:381–388
  PubMed CAS Google Scholar
• Turner WM, Tsuang MT (1990) Impact of substance abuse on the course and outcome of schizophrenia. Schizophr Bull 16:87–95
  PubMed CAS Google Scholar
• Wobrock T, Sittinger H, Behrendt B, D’Amelio R, Falkai P, Caspari D (2007) Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 257:203–210
  Article PubMed Google Scholar
• Woodruff PW, McManus IC, David AS (1995) Meta-analysis of corpus callosum size in schizophrenia. J Neurol Neurosurg Psychiatry 58:457–461
  Article PubMed CAS Google Scholar
• Zavitsanou K, Garrick T, Huang XF (2004) Selective antagonist [3H] SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28:355–360
  Article PubMed CAS Google Scholar